Alexza Pharmaceuticals Inc. Uncategorized Contracts & Agreements

65 Contracts & Agreements

Recent Contracts

Underlying Asset (Filed With SEC on April 29, 2016)
CONFIDENTIAL RELEASEAGREEMENT (Filed With SEC on May 22, 2015)
Executive Officer (Filed With SEC on August 2, 2011)
Executive Officer (Filed With SEC on August 2, 2011)
ALEXZA PHARMACEUTICALS, INC. (Filed With SEC on May 3, 2011)
Current assets (Filed With SEC on November 9, 2010)
Current assets (Filed With SEC on November 9, 2010)
Exhibit Number (Filed With SEC on August 5, 2010)
Exhibit Number (Filed With SEC on August 5, 2010)
Current assets (Filed With SEC on July 26, 2010)
Current assets (Filed With SEC on July 26, 2010)
Current assets (Filed With SEC on July 26, 2010)
Current assets (Filed With SEC on July 26, 2010)
AZ-004 (Staccato loxapine). We are developing AZ-004 for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder. In December 2009, we submitted our... (Filed With SEC on March 9, 2010)
AZ-004 (Staccato loxapine). We are developing AZ-004 for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder. In December 2009, we submitted our... (Filed With SEC on March 9, 2010)
ALEXZA PHARMACEUTICALS, INC. (Filed With SEC on September 30, 2009)
ALEXZA PHARMACEUTICALS, INC. (Filed With SEC on September 30, 2009)
ALEXZA PHARMACEUTICALS, INC. (Filed With SEC on August 26, 2009)
Financial Statements (Unaudited) (Filed With SEC on August 5, 2009)
Exhibit Number (Filed With SEC on June 26, 2009)
Exhibit Number (Filed With SEC on June 26, 2009)
Exhibit Number (Filed With SEC on June 26, 2009)
Current assets (Filed With SEC on May 11, 2009)
AZ-004 (Staccato loxapine). We are developing AZ-004 for the acute treatment of agitation in patients with schizophrenia or bipolar disorder. We project a new drug application, or... (Filed With SEC on March 10, 2009)
AZ-004 (Staccato loxapine). We are developing AZ-004 for the acute treatment of agitation in patients with schizophrenia or bipolar disorder. We project a new drug application, or... (Filed With SEC on March 10, 2009)
INDEMNITY AGREEMENT (Filed With SEC on July 14, 2008)
Current assets (Filed With SEC on November 1, 2007)
Current assets (Filed With SEC on August 13, 2007)
AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. In December 2006, we completed enrollment of an at-home 400... (Filed With SEC on March 29, 2007)
AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. In December 2006, we completed enrollment of an at-home 400... (Filed With SEC on March 29, 2007)
AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. In December 2006, we completed enrollment of an at-home 400... (Filed With SEC on March 29, 2007)
AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. In December 2006, we completed enrollment of an at-home 400... (Filed With SEC on March 29, 2007)
AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. In December 2006, we completed enrollment of an at-home 400... (Filed With SEC on March 29, 2007)
AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. In December 2006, we completed enrollment of an at-home 400... (Filed With SEC on March 29, 2007)
AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. In December 2006, we completed enrollment of an at-home 400... (Filed With SEC on March 29, 2007)
AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. In December 2006, we completed enrollment of an at-home 400... (Filed With SEC on March 29, 2007)
AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. In December 2006, we completed enrollment of an at-home 400... (Filed With SEC on March 29, 2007)
AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. In December 2006, we completed enrollment of an at-home 400... (Filed With SEC on March 29, 2007)
AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. According to the National Headache Foundation,... (Filed With SEC on February 15, 2006)
AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. According to the National Headache Foundation,... (Filed With SEC on February 15, 2006)